Research from the USA has found people taking Omeprazole and other PPIs suffer much more often than those who don't ...

The scenario is not uncommon: A patient taking prophylactic aspirin develops upper gastrointestinal bleeding but has compelling indications for antiplatelet therapy. What is the best approach for this ...

Esomeprazole magnesium oral capsule is a generic prescription drug that’s used to treat conditions caused by excess stomach acid production. Its delayed-release formulation releases the drug into your ...

Nial Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance. He is a ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for esomeprazole magnesium delayed-release capsules USP, 20 mg (OTC), determined by ...

Newark, March 04, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the global Esomeprazole market will grow from USD 1.91 Billion in 2023 to USD 3.22 Billion by 2033. When combined therapy ...

Fexuprazan’s noninferior efficacy for treating erosive esophagitis makes it a suitable substitute for proton pump inhibitors. Fexuprazan has noninferior efficacy to esomeprazole in patients with ...

Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules ...

Drugmaker Granules India has received U.S. Food and Drug Administration approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg, a generic version of AstraZeneca ...

Granules India Limited announced that the USFDA approved its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg. These capsules serve ...